Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Stem Cell Reports ; 16(4): 708-716, 2021 04 13.
Article in English | MEDLINE | ID: mdl-33798450

ABSTRACT

During X chromosome inactivation (XCI), the inactive X chromosome (Xi) is recruited to the nuclear lamina at the nuclear periphery. Beside X chromosome reactivation resulting in a highly penetrant aging-like hematopoietic malignancy, little is known about XCI in aged hematopoietic stem cells (HSCs). Here, we demonstrate that LaminA/C defines a distinct repressive nuclear compartment for XCI in young HSCs, and its reduction in aged HSCs correlates with an impairment in the overall control of XCI. Integrated omics analyses reveal higher variation in gene expression, global hypomethylation, and significantly increased chromatin accessibility on the X chromosome (Chr X) in aged HSCs. In summary, our data support the role of LaminA/C in the establishment of a special repressive compartment for XCI in HSCs, which is impaired upon aging.


Subject(s)
Cellular Senescence/genetics , Hematopoietic Stem Cells/metabolism , X Chromosome Inactivation/genetics , Animals , Chromatin/metabolism , Chromatin Immunoprecipitation Sequencing , Humans , Lamin Type A/metabolism , Mice, Inbred C57BL , Transposases/metabolism , X Chromosome/genetics
3.
Nat Cell Biol ; 21(11): 1309-1320, 2019 11.
Article in English | MEDLINE | ID: mdl-31685996

ABSTRACT

With ageing, intrinsic haematopoietic stem cell (HSC) activity decreases, resulting in impaired tissue homeostasis, reduced engraftment following transplantation and increased susceptibility to diseases. However, whether ageing also affects the HSC niche, and thereby impairs its capacity to support HSC function, is still widely debated. Here, by using in-vivo long-term label-retention assays we demonstrate that aged label-retaining HSCs, which are, in old mice, the most quiescent HSC subpopulation with the highest regenerative capacity and cellular polarity, reside predominantly in perisinusoidal niches. Furthermore, we demonstrate that sinusoidal niches are uniquely preserved in shape, morphology and number on ageing. Finally, we show that myeloablative chemotherapy can selectively disrupt aged sinusoidal niches in the long term, which is linked to the lack of recovery of endothelial Jag2 at sinusoids. Overall, our data characterize the functional alterations of the aged HSC niche and unveil that perisinusoidal niches are uniquely preserved and thereby protect HSCs from ageing.


Subject(s)
Aging/genetics , Capillaries/metabolism , Hematopoietic Stem Cells/metabolism , Homeostasis/genetics , Stem Cell Niche/genetics , Aging/metabolism , Animals , Bone Marrow/drug effects , Bone Marrow/metabolism , Capillaries/cytology , Capillaries/drug effects , Cell Differentiation/drug effects , Cell Division/drug effects , Cell Polarity/drug effects , Cell Tracking/methods , Doxycycline/pharmacology , Fluorouracil/pharmacology , Gene Expression Regulation , Genes, Reporter , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Hematopoietic Stem Cell Transplantation , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/drug effects , Histones/genetics , Histones/metabolism , Homeostasis/drug effects , Jagged-2 Protein/genetics , Jagged-2 Protein/metabolism , Mice , Mice, Inbred C57BL , Mice, Transgenic , Myeloablative Agonists/pharmacology , Stem Cell Niche/drug effects
4.
Stem Cell Reports ; 9(5): 1359-1368, 2017 11 14.
Article in English | MEDLINE | ID: mdl-29056333

ABSTRACT

The spindle assembly checkpoint plays a pivotal role in preventing aneuploidy and transformation. Many studies demonstrate impairment of this checkpoint in cancer cells. While leukemia is frequently driven by transformed hematopoietic stem and progenitor cells (HSPCs), the biology of the spindle assembly checkpoint in such primary cells is not very well understood. Here, we reveal that the checkpoint is fully functional in murine progenitor cells and, to a lesser extent, in hematopoietic stem cells. We show that HSPCs arrest at prometaphase and induce p53-dependent apoptosis upon prolonged treatment with anti-mitotic drugs. Moreover, the checkpoint can be chemically and genetically abrogated, leading to premature exit from mitosis, subsequent enforced G1 arrest, and enhanced levels of chromosomal damage. We finally demonstrate that, upon checkpoint abrogation in HSPCs, hematopoiesis is impaired, manifested by loss of differentiation potential and engraftment ability, indicating a critical role of this checkpoint in HSPCs and hematopoiesis.


Subject(s)
Hematopoietic Stem Cells/cytology , M Phase Cell Cycle Checkpoints , Animals , Antimitotic Agents/pharmacology , Apoptosis , Cells, Cultured , Hematopoiesis , Hematopoietic Stem Cells/drug effects , Hematopoietic Stem Cells/metabolism , Mice , Mice, Inbred C57BL , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...